Clinical features and management of odontogenic keratocysts in Gorlin-Goltz syndrome.

IF 2.7
J T W Li, C C J Wan, A W K Yeung, Y Y Leung, Y-X Su
{"title":"Clinical features and management of odontogenic keratocysts in Gorlin-Goltz syndrome.","authors":"J T W Li, C C J Wan, A W K Yeung, Y Y Leung, Y-X Su","doi":"10.1016/j.ijom.2025.06.009","DOIUrl":null,"url":null,"abstract":"<p><p>One of the frequent manifestations of Gorlin-Goltz syndrome (GGS), a rare autosomal dominant disorder, is the development of odontogenic keratocysts (OKCs). The aim of this study was to evaluate the efficacy and safety of treatment modalities for OKCs in GGS patients, and their corresponding recurrence/new lesion rates and complications. Twelve GGS patients (eight male, four female) with 36 OKCs were included. Common clinical features of GGS were calcification of the falx cerebri (eight patients, 66.7%), macrocephaly (seven patients, 58.3%), and frontal bossing (six patients, 50%). Enucleation with Carnoy's solution was the primary treatment for 10 patients, while two underwent marsupialization. The mean follow-up was 13.3 years. Nine (75%) of the patients did not experience any early complications (up to 1 month postoperative). The OKC recurrence/new lesion rate was 83.3% after surgical treatment (enucleation or marsupialization), with five patients (41.7%) experiencing two occurrences of OKCs during follow-up (range 2.7-29.9 years). Enucleation of OKCs with Carnoy's solution is a safe and effective approach in GGS patients. However, the high recurrence/new lesion rate underscores the need for close long-term monitoring for at least 7 years and consideration of more aggressive surgical methods in these patients.</p>","PeriodicalId":94053,"journal":{"name":"International journal of oral and maxillofacial surgery","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of oral and maxillofacial surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ijom.2025.06.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

One of the frequent manifestations of Gorlin-Goltz syndrome (GGS), a rare autosomal dominant disorder, is the development of odontogenic keratocysts (OKCs). The aim of this study was to evaluate the efficacy and safety of treatment modalities for OKCs in GGS patients, and their corresponding recurrence/new lesion rates and complications. Twelve GGS patients (eight male, four female) with 36 OKCs were included. Common clinical features of GGS were calcification of the falx cerebri (eight patients, 66.7%), macrocephaly (seven patients, 58.3%), and frontal bossing (six patients, 50%). Enucleation with Carnoy's solution was the primary treatment for 10 patients, while two underwent marsupialization. The mean follow-up was 13.3 years. Nine (75%) of the patients did not experience any early complications (up to 1 month postoperative). The OKC recurrence/new lesion rate was 83.3% after surgical treatment (enucleation or marsupialization), with five patients (41.7%) experiencing two occurrences of OKCs during follow-up (range 2.7-29.9 years). Enucleation of OKCs with Carnoy's solution is a safe and effective approach in GGS patients. However, the high recurrence/new lesion rate underscores the need for close long-term monitoring for at least 7 years and consideration of more aggressive surgical methods in these patients.

Gorlin-Goltz综合征牙源性角化囊肿的临床特点及治疗。
Gorlin-Goltz综合征(GGS)是一种罕见的常染色体显性遗传病,其常见表现之一是牙源性角化囊肿(OKCs)的发展。本研究的目的是评估GGS患者OKCs治疗方式的有效性和安全性,以及相应的复发率/新发病变率和并发症。12例GGS患者(男8例,女4例),36例OKCs。GGS的常见临床特征为大脑镰钙化(8例,66.7%)、大头畸形(7例,58.3%)、额部隆起(6例,50%)。10例患者的主要治疗方法为卡诺依氏液去核,2例患者行有袋化。平均随访时间为13.3年。9例(75%)患者未出现任何早期并发症(术后1个月)。手术治疗(去核或有袋化)后OKC复发率/新病灶率为83.3%,5例患者(41.7%)在随访期间(2.7-29.9年)出现两次OKC。Carnoy溶液在GGS患者中是一种安全有效的OKCs去核方法。然而,高复发率/新发病变率强调了对这些患者进行至少7年的密切长期监测和考虑更积极的手术方法的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信